SCHEMBL7015686

SCHEMBL7015686

C#CC[C@@]12CCC[C@H]1[C@@H]1CCC3CCCC[C@@H]3[C@H]1CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30468591 0.86
SCHEMBL5715444 0.80 GRIN1 (0.34)
SCHEMBL5200034 0.80 GRIN1 (0.34)
SCHEMBL30468592 0.79 GRIN1 (0.33)
SCHEMBL11758576 0.74 GRIN1 (0.31)
SCHEMBL30514140 0.74
SCHEMBL30538461 0.73 GRIN1 (0.30)
SCHEMBL10821270 0.70 CYP19A1 (0.47)
Ethyne SCHEMBL7015681 0.69 GRIN1 (0.52)
SCHEMBL374356 0.68 GRIN1 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116392450-A Subcutaneous implant containing estrogen and method for preparing same 江苏集萃新型药物制剂技术研究所有限公司 2023-07-07 CN claimed
CN-119280495-A Shape memory isolation film degradable in uterine cavity and preparation method thereof 上海瑞凝生物科技有限公司 2025-01-10 CN disclosed
EP-0994713-B1 USE OF A 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS AKZO NOBEL NV (NL) 2003-11-05 EP disclosed
EP-0994713-A1 USE OF A 7$g(a)-METHYL-17$g(a)-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS Akzo Nobel N.V. (NL) 2000-04-26 EP disclosed